AYOOSH KAKKAR: Open Payments
NPI 1669992137 · EL SEGUNDO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 28 payments from 6 companies in 2025. Trend: 2023 $849 · 2024 $2,165 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $390 |
| Janssen Pharmaceuticals, Inc | 11 | $378 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $278 |
| E.R. Squibb & Sons, L.L.C. | 7 | $219 |
| Axsome Therapeutics, Inc. | 1 | $121 |
| Neurocrine BioSciences, Inc. | 1 | $89 |
Products named: VRAYLAR, INVEGA SUSTENNA, CAPLYTA, Auvelity, COBENFY, INGREZZA, SPRAVATO.
Industry payments across CA — which companies pay providers there.
